Mass Ave Global’s Insulet PODD Stock Holding History

Mass Ave Global’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,586	Closed	-$2.43M	–	47
2022 Q3	$2.43M	Buy	+10,586	New	+$2.65M	0.6%	25

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mass Ave Global's PODD Position: Q4 2022 in Review

Mass Ave Global sold out of Insulet (PODD) in Q4 2022, closing a stake of 10,586 shares — an estimated $2.43M sold.

Mass Ave Global first reported a position in PODD in Q3 2022 and held it in 1 quarter. The position peaked at $2.43M in Q3 2022. 525 funds tracked by Wall St. Rank hold PODD as of Q4 2022.

Mass Ave Global reported no remaining Insulet position as of Q4 2022 after selling out during the quarter.
Mass Ave Global sold 10,586 Insulet shares in Q4 2022, an estimated $2.43M.
Mass Ave Global first reported a position in Insulet in Q3 2022 and held it in 1 quarter.
Mass Ave Global's Insulet position peaked at $2.43M in Q3 2022.
525 funds tracked by Wall St. Rank held Insulet as of Q4 2022.

Based on Mass Ave Global's 13F filing for Q4 2022, filed 14 Feb 2023.